Bank of New York Mellon Corp - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 70 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$11,686,000
+109.1%
155,302
-25.4%
0.00%
+200.0%
Q1 2022$5,588,000
-43.9%
208,106
-0.4%
0.00%
-50.0%
Q4 2021$9,968,000
-31.3%
208,990
-4.3%
0.00%
-33.3%
Q3 2021$14,514,000
-6.8%
218,482
+9.4%
0.00%0.0%
Q2 2021$15,580,000
+4.9%
199,700
+27.2%
0.00%0.0%
Q1 2021$14,847,000
-28.4%
156,958
-7.7%
0.00%
-40.0%
Q4 2020$20,727,000
+55.0%
170,107
+11.2%
0.01%
+66.7%
Q3 2020$13,369,000
+70.4%
153,036
+26.0%
0.00%
+50.0%
Q2 2020$7,847,000
+68.4%
121,485
+16.4%
0.00%0.0%
Q1 2020$4,661,000
-27.1%
104,376
+1.6%
0.00%0.0%
Q4 2019$6,397,000
+263.1%
102,682
+119.2%
0.00%
Q3 2019$1,762,000
+40.7%
46,849
+52.3%
0.00%
Q2 2019$1,252,00030,7590.00%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q2 2019.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders